CHE Chemed Corp

Price (delayed)

$641.93

Market cap

$9.7B

P/E Ratio

35.45

Dividend/share

$1.58

EPS

$18.11

Enterprise value

$9.48B

Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of ...

Highlights
Chemed's quick ratio has soared by 99% YoY and by 24% from the previous quarter
The debt has dropped by 72% since the previous quarter and by 72% year-on-year
The price to earnings (P/E) is 24% higher than the 5-year quarterly average of 28.8 and 6% higher than the last 4 quarters average of 33.4

Key stats

What are the main financial stats of CHE
Market
Shares outstanding
15.12M
Market cap
$9.7B
Enterprise value
$9.48B
Valuations
Price to book (P/B)
8.73
Price to sales (P/S)
4.27
EV/EBIT
26.82
EV/EBITDA
22.88
EV/Sales
4.19
Earnings
Revenue
$2.26B
EBIT
$353.48M
EBITDA
$414.34M
Free cash flow
$274.09M
Per share
EPS
$18.11
Free cash flow per share
$18.21
Book value per share
$73.55
Revenue per share
$150.46
TBVPS
$65.97
Balance sheet
Total assets
$1.67B
Total liabilities
$560.22M
Debt
$38.64M
Equity
$1.11B
Working capital
$188.79M
Liquidity
Debt to equity
0.03
Current ratio
1.61
Quick ratio
1.43
Net debt/EBITDA
-0.54
Margins
EBITDA margin
18.3%
Gross margin
35.3%
Net margin
12%
Operating margin
15%
Efficiency
Return on assets
17.7%
Return on equity
27.5%
Return on invested capital
67.6%
Return on capital employed
26.1%
Return on sales
15.6%
Dividend
Dividend yield
0.25%
DPS
$1.58
Payout ratio
8.7%

CHE stock price

How has the Chemed stock price performed over time
Intraday
-0.36%
1 week
-0.31%
1 month
2.08%
1 year
21.35%
YTD
9.78%
QTD
9.78%

Financial performance

How have Chemed's revenue and profit performed over time
Revenue
$2.26B
Gross profit
$798.82M
Operating income
$340.57M
Net income
$272.51M
Gross margin
35.3%
Net margin
12%
The net income has grown by 11% since the previous quarter and by 9% year-on-year
Chemed's operating income has increased by 10% from the previous quarter
The net margin is up by 9% since the previous quarter and by 2.6% year-on-year
The operating margin has increased by 7% QoQ but it has decreased by 7% YoY

Growth

What is Chemed's growth rate over time

Valuation

What is Chemed stock price valuation
P/E
35.45
P/B
8.73
P/S
4.27
EV/EBIT
26.82
EV/EBITDA
22.88
EV/Sales
4.19
The price to earnings (P/E) is 24% higher than the 5-year quarterly average of 28.8 and 6% higher than the last 4 quarters average of 33.4
The EPS has increased by 11% from the previous quarter and by 8% YoY
Chemed's equity has increased by 39% YoY and by 9% from the previous quarter
The P/B is 7% less than the 5-year quarterly average of 9.4 but 6% more than the last 4 quarters average of 8.3
CHE's P/S is 22% above its 5-year quarterly average of 3.5 and 16% above its last 4 quarters average of 3.7
The revenue rose by 6% year-on-year

Efficiency

How efficient is Chemed business performance
The ROE has contracted by 21% YoY but it has grown by 2.6% from the previous quarter
The company's return on invested capital rose by 18% YoY and by 14% QoQ
The ROS has increased by 8% from the previous quarter
The ROA rose by 7% since the previous quarter but it has declined by 3.8% year-on-year

Dividends

What is CHE's dividend history
DPS
$1.58
Dividend yield
0.25%
Payout ratio
8.7%
Recent dividends

Financial health

How did Chemed financials performed over time
Chemed's total assets is 198% higher than its total liabilities
Chemed's quick ratio has soared by 99% YoY and by 24% from the previous quarter
CHE's current ratio has soared by 75% YoY and by 21% from the previous quarter
The debt is 97% smaller than the equity
CHE's debt to equity has dropped by 82% year-on-year and by 77% since the previous quarter
The debt has dropped by 72% since the previous quarter and by 72% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.